The strongest prognostic power (P = 0.0024 and 0.00065, Fig. 4c) came from the gene-set pair of two ENSC markers (CDK2 and CDKN344) with two NB tumour suppressors (CDKN1B and CDKN2D45, 46). Here, CDK2 is linked to neuroblastoma.